Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq Sell-Off: Buy the Dip on This "Magnificent Seven" Stock Before It Takes Off
08:30am, Tuesday, 13'th Aug 2024
Meta Platforms' shares are down along with other big tech stocks recently. However, this means very little for the company's long-term prospects.
Wall Street is priming for a positive start on Tuesday, as the market resiliently holds onto optimism regarding receiving benign inflation data, which will likely seal the fate of a rate cut. The prod
3 Underrated Nasdaq 100 Stocks to Turn $10,000 Into $50,000 by 2029
07:20am, Tuesday, 13'th Aug 2024
Finding underrated Nasdaq 100 stocks to buy in 2024 will not be a walk in the park. Although the index recently experienced a small dip, many of the companies are still extremely expensive.
SOBRsafe Provides Q2 2024 Quarterly Update
09:30pm, Monday, 12'th Aug 2024
DENVER, CO / ACCESSWIRE / August 12, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today provided a comprehensive update on th
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:15pm, Monday, 12'th Aug 2024
BEIJING, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in Ch
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 12'th Aug 2024
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
01:52pm, Monday, 12'th Aug 2024
The tech sector selloff that began in July gave investors the jitters. The best tech stocks were in freefall after carrying the Nasdaq 100 to new heights.
Nasdaq 100: Nvidia Surge Lifts Tech Stocks as Investors Brace for Inflation Data
11:41am, Monday, 12'th Aug 2024
Stocks mixed as markets brace for key inflation data this week. Nvidia boosts Nasdaq, while small caps falter.
3 Bullish Tech Stocks That Are Ignoring the Nasdaq Selloff
08:30am, Sunday, 11'th Aug 2024
The tech-heavy Nasdaq Composite index has officially entered into correction territory, having fallen more than 10% from its record high set just a few weeks ago in July. Many high-flying tech stocks
Nasdaq Sell-Off: 3 Smart Stocks to Buy Right Now
06:53am, Sunday, 11'th Aug 2024
Global-e has a growing, niche e-commerce business. Roku's accounts and streaming hours continue to increase.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00pm, Friday, 09'th Aug 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2024
05:15pm, Friday, 09'th Aug 2024
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2024, short interest in 3,043 Nasdaq Global MarketSM securities totaled 11,985,723,964 shares compared with 12
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 09'th Aug 2024
CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives o
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 09'th Aug 2024
BRISBANE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on August 6, 2024, the Compensation Committee granted inducement awards consisting of a
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 09'th Aug 2024
SAN FRANCISCO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
